Abitec Corporation has acquired Larodan AB, a manufacturer and international marketer of high purity research-grade lipids.
Abitec Corporation (Columbus, OH) has acquired Larodan AB (Stockholm, Sweden), a manufacturer and international marketer of high purity research-grade lipids. The strategic acquisition expands Abitec’s functional lipid product offerings and scientific capabilities to better serve the pharmaceutical, nutritional, and industrial market sectors.
“Larodan is a world leader in the field of analytical-grade lipids and their scientific capabilities will not only expand ABITEC’s technical expertise but will also provide us with a strategic R&D location in Europe. The Larodan team has done an exceptional job in the development, manufacturing and global commercialization of their unique and highly specialized lipid reagents and we are thrilled to have them join the Abitec team,” said Jeff Walton, CEO of Abitec, in a press release. “The acquisition will undoubtedly bring ABITEC to the forefront of the high-purity lipid market.”
The acquisition will also advance Abitec into the field of lipodomics, with the potential to offer researchers unparalleled capabilities to identify the numerous roles of lipids across a vast spectrum of health and disease states at the chemical level.